Protagonist Therapeutics (NASDAQ:PTGX) executives said March 18 that the U.S. Food and Drug Administration has approved ICOTYDE for the treatment of moderate-to-severe plaque psoriasis in adults and p ...

Johnson & Johnson (NYSE:JNJ) is one of the stocks mentioned during the show, as we cover everything Jim Cramer said about the ...

Alumis reported a net loss of $243.3 million for the 2025 fiscal year. While significant, this figure marks a notable improvement from the prior year's loss of $294.2 million. Research and development ...

Straining when going to the toilet is a classic symptom of constipation, and usually occurs when stools are too hard to easily pass.

Or is it worth buying Johnson & Johnson? Codenamed "Osprey" internally, the separation initiative involves a global search for IT and finance specialists. The objective is to establish a fully ...

An itchy scalp is more than just a minor annoyance; it’s often a sign that your roots are struggling with dryness, product buildup, or irritation. Whether you're dealing with seasonal changes, heavy ...

Why do exams, sleepless nights or money worries so often send eczema into overdrive? Scientists have traced a hidden ...

I’ve tried nearly every popular LED face mask out there—but could this one top them all?